Alexion at an excellent entry point, says RW Baird Baird is increasingly confident in Alexion's Solaris prospects both near and long-term. The firm also noted the company's robust pipeline and current valuation and remains buyers of the shares for a recovery into the $125 range. Shares are Outperform rated.
News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.
Alexion price target raised to $199 from $175 at RW Baird Baird raised its price target on Alexion following successful negotiations with the French government regarding reimbursement rates for aHUS. The company raised its guidance and the firm raised its earnings estimates and Soliris estimates and calls Alexion a core large-cap holding. Shares are Outperform rated.